icone plus
Contact Abonnez-vous aux actualités
Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
Insufficient
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia".
Therapeutic use
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
8PPuSqP1M1afb79G
Listen
